BIS vs BBP

Both BIS and BBP are ETFs. BIS has a lower 5-year return than BBP (-25.18% vs 10.63%). BIS has a higher expense ratio than BBP (0.95% vs 0.79%). Below is the comparison between BIS and BBP.

BBP BIS
Segment Equity: U.S. Biotech Inverse Equity: U.S. Biotech
Issuer Virtus ProShares
Net Assets $24.95M $12.31M
Expense Ratio 0.79% 0.95%
Management Style passive (index-based) passive (index-based)
Dividend Yield 0.00% 2.41%
Underlying Index LifeSci Biotechnology Products Index NASDAQ Biotechnology Index
YTD Return 19.34% -50.24%
1-Year Return 18.10% -51.45%
3-Year Return 10.50% -33.87%
5-Year Return 10.63% -25.18%
10-Year Return N/A -40.06%

BIS description

The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) inverse (opposite) of the daily performance of the NASDAQ Biotechnology Index.

BIS performance & returns

YTD Return -50.24%
1-Month Return -12.37%
3-Month Return -19.91%
1-Year Return -51.45%
3-Year Return -33.87%
5-Year Return -25.18%
10-Year Return -40.06%
BIS expense ratio is 0.95%.

BIS holdings

Top 10 Holdings (200.14% of Total Assets)

Name Symbol % Assets
Nasdaq Biotechnology Index Swap Ubs Ag N/A 70.36%
Nasdaq Biotechnology Index Swap Societe Generale N/A 57.04%
Nasdaq Biotechnology Index Swap Bank Of America Na N/A 47.41%
Ishares Biotech (Ibb) Swap Morgan Stanley & Co. International Plc N/A 13.04%
Nasdaq Biotechnology Index Swap Credit Suisse International N/A 4.79%
Nasdaq Biotechnology Index Swap Citibank Na N/A 3.25%
Ishares Biotech (Ibb) Swap Bank Of America Na N/A 3.16%
Nasdaq Biotechnology Index Swap Morgan Stanley & Co. International Plc N/A 1.09%

Other relevant BIS comparisons

You may also want to check out the following BIS comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

BBP description

The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. The Index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering or product candidate.

BBP performance & returns

YTD Return 19.34%
1-Month Return 4.53%
3-Month Return 17.63%
1-Year Return 18.10%
3-Year Return 10.50%
5-Year Return 10.63%
10-Year Return N/A
BBP expense ratio is 0.79%.

BBP holdings

Top 10 Holdings (34.61% of Total Assets)

Name Symbol % Assets
Sage Therapeutics Inc SAGE 4.86%
BeiGene Ltd ADR BGNE 4.34%
Amicus Therapeutics Inc FOLD 3.91%
Ultragenyx Pharmaceutical Inc RARE 3.54%
Blueprint Medicines Corp BPMC 3.51%
Retrophin Inc RTRX 3.17%
Halozyme Therapeutics Inc HALO 2.94%
Insmed Inc INSM 2.90%
United Therapeutics Corp UTHR 2.79%
Seagen Inc Ordinary Shares SGEN 2.65%

Other relevant BBP comparisons

You may also want to check out the following BBP comparisons that investors often look for on Finny

    Or use Finny Compare Wizard to create a comparison you’d like to see.

    You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.

    7-day free trial: Get unlimited comparisons, and stock, ETF and mutual fund analyses for just $15 a month, without ads. Start a free trial. Go ad free!

    Follow Us